CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- 4 Shares withheld for taxes Chief Scientific Officer gave up 12,385 shares (to pay taxes)
- 4 Option exercise Director acquired 11,580 shares (option exercise)
- 4 Option exercise Director acquired 11,580 shares (option exercise)
- 4 Option exercise Director acquired 11,580 shares (option exercise)
- 4 Option exercise Director acquired 11,580 shares (option exercise)
- 4 Option exercise Director acquired 11,580 shares (option exercise)
- 4 Option exercise Director acquired 11,580 shares (option exercise)
- 4 Shares withheld for taxes Chief Medical Officer gave up 9,330 shares (to pay taxes)
- 4 Open-market sale 10% owner sold 300,000 shares at $4.53 ($1,359,000)
- 4 Shares withheld for taxes Chief Financial Officer gave up 677 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Business Officer gave up 5,937 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 18,611 shares (to pay taxes)
- 4 Option exercise President and COO acquired 18,675 shares (option exercise)
- 4 Shares withheld for taxes Chief Financial Officer gave up 6,449 shares (to pay taxes)
Page 1 of 21 · 414 filings